German officials will discuss a reported U.S. attempt to secure the
rights to any coronavirus vaccine developed by a German pharmaceutical
company in crisis meetings on Monday, the country's interior minister
said, amid concerns that the Trump administration was trying to
monopolize the market.
Publisher: Washington Post | Author: Loveday Morris
TAGS
covid-19, extreme measures, governance, and trump agendaDATE PUBLISHED
2020-03-16 (Modified: 2020-03-16)STAR RATING
[Total: 0 Average: 0/5] Please log in to vote